---
schema_version: "secwatch.filing_event.v1"
accession: "0001441683-24-000083"
form_type: "8-K"
ticker: "APPN"
cik: "0001441683"
company_name: "APPIAN CORP"
filed_at: "2024-10-01T23:59:59+00:00"
generated_at: "2026-05-30T23:14:52.965133+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Appian appoints Carl 'Boe' Hartman II to board, effective Oct 1, 2024

## Summary
- Hartman is Co-Founder and CTO of Nomi Health; previously Partner at Goldman Sachs.
- Appointed to Compensation Committee; independent director per Nasdaq and SEC rules.
- Annual retainer of $250,000, paid half cash and half fully-vested Class A shares.
- Term runs until the 2025 annual meeting of stockholders.

## SEC filing metadata
- accession: 0001441683-24-000083
- form_type: 8-K
- ticker: APPN
- cik: 0001441683
- company_name: APPIAN CORP
- filed_at: 2024-10-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1441683/000144168324000083/0001441683-24-000083-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1441683/000144168324000083/appn-20241001.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001441683-24-000083
- JSON: https://secwatch.observer/filing/0001441683-24-000083.json
- Plain text: https://secwatch.observer/filing/0001441683-24-000083.txt

## Key facts
- Executive change
  Carl “Boe” Hartman II was appointed as director at APPIAN CORP.
  - Action: appointed
  - Role: director
  source text: On September 25, 2024, the Board of Directors appointed Carl “Boe” Hartman II to the Board, effective as of October 1, 2024, to serve until our annual meeting of stockholders to be held in 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1441683/000144168324000083/0001441683-24-000083-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.